A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is now exploring a new ...

Scientists are designing mRNA vaccines to produce virus-like nanoparticles, which should lead to a more robust immune ...

A University of Florida research team led by Dr. Elias Sayour, center, developed an mRNA vaccine that boosted the tumor-fighting effects of immunotherapy. An experimental mRNA vaccine developed at the ...

Clinical studies suggest these vaccines can generate immunological memory, allowing lymphocytes to respond to tumor ...

A research team led by Cancer Center at Illinois (CCIL) member Hua Wang has published new research detailing a new mRNA ...

Study found that generic mRNA vaccine prompted anti-cancer reaction in immune system. A University of Florida research team led by UF Health oncologist Elias Sayour, center, developed an mRNA vaccine ...

Moderna said Wednesday that its experimental mRNA-based seasonal flu vaccine generated a stronger immune response against four strains of the flu virus than a currently marketed vaccine in a Phase 3 ...

Up to 88 percent of the mice in the study remained tumor-free, and the team are now turning their attention to human cancers.

To test its broader use, scientists created another version using tumour lysates — basically, cancer cells that had been ...

In September 2025, the Russian Federal Medical and Biological Agency announced that a Russian cancer vaccine had passed ...

WASHINGTON (AP) — The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed to fight respiratory viruses like COVID-19 and the flu.

NEW YORK (PIX11) – U.S. Health Secretary Robert F. Kennedy Jr. has pulled $500 million in funding from mRNA vaccine research, according to the Department of Health and Human Services. “… The data show ...